This Week in Health Care

February 13, 2019

Every Wednesday, Stateside Associates selects some health care-related state and local events to highlight in This Week in Health Care.

To provide feedback, or for more information about these issues or Stateside Associates' Health Care Practice, please contact Robert Holden at (703) 525-7466 or

There are no groups events to report. 


The House Committee on Health and Human Services will hold a public hearing February 14 regarding HB 2494, which prohibits a contract between a health insurer and a health care provider that is issued on or after January 1, 2020, from restricting the method of payment from the health insurer to the health care provider so that the only acceptable payment method is a credit card payment or an electronic funds transfer payment. Contact Kyle Perigard


The Senate Health and Human Services Committee will hold a public hearing February 14 regarding SB 41, which requires health insurance contracts between an insurer and a policyholder to state that the policyholder is required to pay premiums to the carrier through the date that the individual covered is no longer eligible or covered if the policyholder notifies the carrier within 10 business days after the date of ineligibility. Contact Jermaine Collins


The House Commerce and Consumer Affairs Committee will hold a public hearing February 17 regarding HB 703, which requires prescription drug manufacturers to provide written notice, within three calendar days, to the office of the attorney general if it is introducing a new prescription drug to market at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program. Contact Kyle Perigard


The Senate Behavioral Health Subcommittee will hold a public hearing February 14 regarding SB 5431, which establishes the licensure procedures for various facilities intended to provide more options for the continuum of behavioral health care. Contact Jermaine Collins